Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models

Nicholas Syn(National University of Singapore), Wen‐Son Hsieh(National University of Singapore)
Signal Transduction and Targeted Therapy
April 13, 2018
10.1038/s41392-018-0010-0
Cited by 38

Related Papers

The global burden of metabolic disease: Data from 2000 to 2019
|Cell Metabolism|2023|777
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
|Clinical Gastroenterology and Hepatology|2023|126
Utility of the Iwate difficulty scoring system for laparoscopic right posterior sectionectomy: do surgical outcomes differ for tumors in segments VI and VII?
|Surgical Endoscopy|2022|6